When Vaginal Moisturizers and Lubricants Aren’t Enough

What they do, why relief may become incomplete, and when symptoms need evaluation

Vaginal moisturizers and lubricants can both provide meaningful relief from dryness and discomfort, but they are not interchangeable.

A lubricant is used primarily to reduce friction during sexual activity. A vaginal moisturizer is applied regularly to increase or retain moisture for longer periods. Some women need one; some use both.

Relief may become incomplete when the product no longer matches the symptom, when the formulation irritates sensitive tissue, or when dryness is only one part of a broader vulvar, vaginal, urinary, neurological, dermatological, or pelvic-floor problem.

A moisturizer or lubricant that no longer feels sufficient does not automatically prove that the tissue has deteriorated. It also does not prove that a woman needs estrogen, testosterone, or DHEA.

It means the symptom deserves a more specific question:

What is this product designed to address, and what is now limiting comfort?

Key points

Lubricants reduce friction during sexual activity.
Vaginal moisturizers are used regularly to support longer-lasting hydration.
Some moisturizers improve symptoms, but results differ by formulation and study.
It is not accurate to say that every moisturizer simply sits on the surface or has no biological effect.
Burning or stinging may reflect formulation irritation, altered tissue sensitivity, infection, inflammation, or another condition.
Laboratory studies suggest that osmolality, pH, and ingredients can affect vaginal epithelial cells and bacteria, but laboratory findings are not the same as demonstrated clinical harm.
A partial response does not identify the underlying cause by itself.
Persistent or changing symptoms warrant clinical evaluation rather than repeated product escalation.

What is the difference between a lubricant and a moisturizer?

The terms are often used as though they mean the same thing. They do not.

Product	Main purpose	Typical timing	Expected duration
Personal lubricant	Reduces friction and discomfort during sexual activity	Applied immediately before or during activity	Usually minutes to hours
Vaginal moisturizer	Increases or retains moisture between applications	Used regularly, often every few days depending on the product	Usually hours to several days
External vulvar moisturizer	Supports comfort and hydration of external vulvar or vestibular tissue	Used according to the product instructions	Product-specific

Clinical guidance recognizes lubricants and vaginal moisturizers as reasonable nonprescription options, particularly for mild symptoms of genitourinary syndrome of menopause.[1]

The anatomical site matters.

A product intended for external vulvar use should not automatically be inserted into the vagina. A product intended for intravaginal use should not automatically be assumed appropriate for every part of the vulva.

Use each product only at the site and frequency for which it was formulated.

What does a lubricant do?

A lubricant creates a temporary layer that reduces friction between surfaces.

This can:

make penetration more comfortable;
reduce mechanical pulling or dragging;
decrease pain caused primarily by friction;
help protect already-sensitive tissue from repeated mechanical irritation;
improve sexual comfort and, indirectly, sexual enjoyment.

A lubricant does not have to correct the biological cause of dryness to be useful. Reducing friction is itself a legitimate therapeutic goal.

If pain occurs mainly during penetration and improves substantially with adequate lubrication, friction was probably an important contributor.

But a lubricant cannot determine whether the tissue is also affected by:

genitourinary syndrome of menopause;
vulvar dermatosis;
infection;
pelvic-floor overactivity;
vestibulodynia;
neuropathic pain;
inflammation;
medication effects;
inadequate arousal-related blood flow;
another condition.

A lubricant treats friction. It does not diagnose the reason friction became painful.

What does a vaginal moisturizer do?

A vaginal moisturizer is intended to provide more sustained hydration than a lubricant.

Different products use different mechanisms. Some contain mucoadhesive polymers, which help the product remain in contact with the vaginal surface. Others contain humectants, such as hyaluronic acid, which bind water. Some contain oils, emollients, buffering agents, or combinations of ingredients.

This diversity matters.

It is not scientifically accurate to make one universal statement that all vaginal moisturizers:

remain only on the surface;
cannot affect tissue hydration;
cannot affect vaginal pH;
cannot influence epithelial measures;
are biologically inert.

Some clinical trials of hyaluronic-acid and polycarbophil formulations have reported improvements in dryness and other vulvovaginal symptoms.[4,5]

However, evidence for the category remains inconsistent. Products differ in composition, concentration, dose, frequency, pH, osmolality, study population, and outcome measured.

The correct conclusion is therefore:

Some vaginal moisturizers provide meaningful symptom relief, but evidence for one formulation cannot automatically be applied to every moisturizer.

What does the research show?

The evidence is more complicated than either “moisturizers work” or “moisturizers do nothing.”

Clinical guidance

The North American Menopause Society’s 2020 position statement identifies nonhormonal lubricants and moisturizers as appropriate options for many women with mild genitourinary symptoms.[1]

When symptoms are moderate, severe, persistent, or associated with significant tissue change, other therapies or further evaluation may be appropriate.

The 2024 systematic review

A 2024 systematic review evaluated randomized trials of vaginal estrogen, nonestrogen hormonal treatments, and vaginal moisturizers for genitourinary syndrome of menopause.

The authors concluded that vaginal moisturizers may improve vaginal dryness, but the certainty of evidence was low.[2]

Low certainty does not mean that moisturizers cannot help. It means the available studies are too limited or heterogeneous to estimate their effects with high confidence.

The 2018 Vaginal Health Trial

A randomized trial involving 302 postmenopausal women compared:

a low-dose vaginal estradiol tablet;
a polycarbophil vaginal moisturizer;
placebo tablets and placebo gel.

Symptoms improved in all three groups. Neither the estradiol-tablet group nor the moisturizer group improved significantly more than the dual-placebo group over 12 weeks.[3]

This study is sometimes interpreted as proving that moisturizers are ineffective. That conclusion is too broad.

The placebo gel itself provided hydration and lubrication. The study therefore showed that the tested branded moisturizer did not outperform the comparison gel under those trial conditions—not that contact gels or moisturizers provide no relief.

Hyaluronic-acid and polycarbophil studies

A 2022 randomized trial compared a polycarbophil moisturizer with a hyaluronic-acid gel in women with vaginal dryness during the late menopausal transition. Both groups improved, and the polycarbophil product met the study’s criterion for noninferiority to hyaluronic acid.[4]

A 2024 randomized pilot trial compared vaginal hyaluronic acid with vaginal estrogen cream for 12 weeks. Forty-five women contributed follow-up data. Symptoms and several secondary outcomes improved in both groups, with no clinically meaningful difference detected between them.[5]

Because this was a small pilot study, it should not be interpreted as proving that all hyaluronic-acid products are equivalent to all vaginal-estrogen treatments.

Together, the studies show that:

moisturizers can be useful;
formulation matters;
trial results differ;
individual responses vary;
no single study settles the question for every product.

Why might a moisturizer or lubricant stop feeling sufficient?

There are several possible explanations.

1. The product is treating friction, but the symptom is no longer primarily friction

A lubricant may work well when discomfort is caused mainly by insufficient lubrication during sexual activity.

It may become less sufficient if burning or pain begins to occur:

at rest;
with clothing;
during urination;
at the vaginal opening before penetration;
after contact rather than during friction;
in association with visible skin change.

Those patterns suggest that something beyond mechanical friction may be contributing.

2. Dryness is only one component of the problem

Vulvovaginal symptoms may involve several biological systems:

epithelial integrity;
connective tissue;
local hydration;
blood flow;
sensory nerves;
pelvic-floor muscle tone;
inflammatory activity;
hormone signaling;
the vaginal microbial environment.

A moisturizer may improve one component without resolving the others.

For example, tissue may feel less dry while pain persists because the dominant problem is pelvic-floor tension, vestibular sensitivity, inflammation, or a vulvar dermatosis.

Related article: What Causes Vaginal Dryness After Menopause?

3. The application site does not match the symptom

A vaginal insert may improve internal vaginal dryness without adequately addressing external vulvar or vestibular discomfort.

An external vulvar moisturizer may support the labia or vestibule but may not address symptoms arising higher within the vagina.

Women often use the word “vaginal” to describe the entire genital area, but the vagina, vestibule, labia, clitoris, urethra, and surrounding skin are distinct structures.

A useful question is:

Where exactly is the dryness, burning, friction, or pain occurring?

4. The formulation may not suit the tissue

Products within the same category can differ substantially.

Variables include:

pH;
osmolality;
viscosity;
preservatives;
fragrances;
flavoring agents;
warming or cooling ingredients;
alcohols;
glycols;
oils;
polymers;
botanical ingredients;
active compounds.

A product may be well tolerated by one woman and irritating to another.

This does not mean that the woman is unusually sensitive or that the product is inherently unsafe. It means the interaction between formulation, tissue state, dose, frequency, and individual biology matters.

5. The symptom or underlying condition has changed

Genitourinary symptoms can fluctuate or evolve.

A woman who initially had uncomplicated dryness may later develop:

contact dermatitis;
candidiasis or another infection;
lichen sclerosus or another dermatosis;
urinary symptoms;
pelvic-floor dysfunction;
vestibulodynia;
neuropathic pain;
irritation from repeated products;
bleeding or tissue fragility.

Increasing the amount or frequency of moisturizer does not address these conditions.

6. The expected outcome is outside the product’s main function

A moisturizer may improve comfort but not restore:

spontaneous desire;
arousal-related blood flow;
genital sensation;
orgasm;
pelvic-floor relaxation;
central sexual motivation.

A lubricant may make sex more comfortable, which can indirectly improve arousal or enjoyment. But lubrication and sexual desire are not the same physiological process.

Related article: Why Does Desire Decline in Midlife?

Can using more product make symptoms worse?

Yes, but there is no single explanation.

Repeated burning or stinging may reflect:

contact irritation;
allergy;
an unsuitable pH;
a highly concentrated formulation;
fragrance or flavoring;
warming or cooling agents;
an existing epithelial injury;
infection;
inflammation;
increased sensory sensitivity.

Laboratory research has also raised concerns about markedly hyperosmolar lubricants.

Osmolality describes the concentration of dissolved particles in a fluid. In a three-dimensional human vaginal epithelial model, lubricants with very high osmolality reduced barrier integrity and produced structural damage.[6]

A separate laboratory study found that lubricant osmolality was associated with epithelial-cell stress and cytotoxicity, although the effects differed among products.[7]

Some lubricants have also altered the growth or epithelial colonization of vaginal Lactobacillus species in vitro.[8]

These findings are important, but they require careful interpretation:

the studies were performed primarily in cell or reconstructed-tissue models;
exposure conditions may not reproduce real-world use;
they do not establish that every hyperosmolar product causes clinical injury;
they do not prove that every low-osmolality product will be well tolerated;
formulation cannot be judged by one ingredient alone.

The practical conclusion is not to fear every lubricant.

It is to recognize that formulation matters, and that a product causing repeated discomfort should not be continually reapplied.

Should I look for a “clean” product?

“Clean” is a marketing term, not a standardized scientific category.

A product described as natural, botanical, organic, or clean can still cause irritation or allergy. A synthetic ingredient is not automatically harmful, and a plant-derived ingredient is not automatically gentle.

What should I do if the product worked at first and now does not?

First, clarify what has changed.

Ask:

Is relief shorter, or is there no relief at all?
Is the symptom internal, external, or both?
Is discomfort limited to sexual activity, or present at rest?
Is the symptom dryness, friction, burning, itching, tearing, pain, numbness, or reduced sensation?
Did the product itself begin to sting?
Has there been a new medication, infection, health condition, or hormone change?
Are there visible skin changes, discharge, odor, bleeding, or urinary symptoms?

A shorter duration of relief may justify changing the product or application schedule.

A change in the type or location of symptoms may justify a clinical examination.

The important point is not simply to apply more of the same product without reconsidering the problem.

Does a partial response mean the moisturizer failed?

No.

A partial response can be informative.

If a moisturizer reduces dryness but not burning, dryness and burning may have different contributing mechanisms.

If a lubricant reduces penetration pain but pain remains at the vestibule before penetration, friction may not be the only issue.

If external comfort improves but internal vaginal symptoms remain, the application site may not match the full symptom pattern.

A partial response shows which aspect of the experience changed. It does not identify the remaining cause by itself.

Does this mean I need estrogen?

Not necessarily.

Vaginal estrogen is an established treatment for many women with genitourinary syndrome of menopause, but an incomplete response to a moisturizer does not diagnose estrogen deficiency.

Persistent symptoms may reflect:

estrogen-responsive tissue change;
androgen-responsive tissue change;
infection;
inflammatory disease;
dermatological disease;
pelvic-floor dysfunction;
neuropathic pain;
medication effects;
another condition.

Treatment decisions should be based on the clinical pattern, examination, history, risks, and personal preferences.

Does this mean I need DHEA?

Not necessarily.

DHEA is a steroid precursor that vulvovaginal tissues can convert locally into androgens and estrogens. That biology does not mean every woman whose moisturizer becomes insufficient needs DHEA.

Evidence from prescription intravaginal prasterone cannot automatically be applied to:

oral DHEA;
external vulvar DHEA;
every DHEA dose;
every formulation;
every symptom.

A moisturizer plateau is not a diagnostic test for low tissue DHEA activity.

Related article: DHEA and Vulvar Tissue: What the Evidence Shows.

When should persistent symptoms be evaluated?

Seek clinical evaluation when dryness or discomfort:

is new, sudden, or worsening;
persists despite appropriate product use;
occurs at rest;
repeatedly causes tearing or bleeding;
is associated with discharge or odor;
produces urinary burning or urgency;
is accompanied by visible white patches, redness, ulcers, fissures, or skin change;
causes pain at the vaginal opening;
is associated with numbness or marked sensory change;
follows a new medication or cancer treatment;
substantially interferes with daily life or sexual activity.

A clinician may need to distinguish GSM from infection, dermatosis, pelvic-floor dysfunction, vulvodynia, contact irritation, urinary disease, or another cause.

Frequently asked questions

Can I use a moisturizer and a lubricant together?

Often, yes.

A moisturizer may be used regularly for ongoing comfort, while a lubricant is added during sexual activity to reduce friction.

Follow the instructions for each product, particularly regarding vaginal versus external use and compatibility with condoms or devices.

Is hyaluronic acid a vaginal moisturizer?

Hyaluronic acid is a water-binding molecule used in some vaginal moisturizers and suppositories.

Small randomized trials have reported improvement in dryness and other GSM symptoms, but formulations vary and the evidence base is still limited.[4,5]

A positive study of one hyaluronic-acid product does not prove that every product containing hyaluronic acid will have the same effect.

Why does my vaginal moisturizer sting?

Possible explanations include:

formulation irritation;
fragrance or flavoring;
preservatives;
pH or osmolality;
an existing epithelial injury;
infection;
inflammation;
contact dermatitis;
heightened nerve sensitivity.

Repeated stinging should not be treated as proof that the product is “working.” Stop using the product and seek advice if symptoms persist.

Are vaginal moisturizers only temporary?

Their effects are not permanent, so repeated application is generally needed.

However, “temporary” does not mean unimportant. Sustained symptom relief between applications may meaningfully improve daily comfort and sexual activity.

Some formulations may also affect vaginal pH or other local measures, but these effects are product-specific and not established for the entire category.

Can a moisturizer rebuild vaginal tissue?

That claim is too broad without product-specific clinical evidence.

Some formulations have improved clinical symptoms and vaginal measures in trials. But terms such as “rebuild,” “restore,” or “reverse atrophy” require evidence for the specific product, dose, population, application site, and outcome.

Why did the moisturizer help initially but stop later?

Possibilities include:

the symptom became more severe;
a different mechanism became dominant;
the application site no longer matched the symptom;
the formulation began to irritate the tissue;
another condition developed;
expectations expanded beyond hydration or friction reduction.

The pattern is worth investigating, but it does not prove one specific cause.

Is vaginal dryness always caused by menopause?

No.

Dryness can also be associated with:

breastfeeding;
postpartum hormonal change;
medications;
cancer treatment;
surgical menopause;
autoimmune or inflammatory conditions;
inadequate arousal;
stress;
infection;
dermatological disease;
irritant exposure.

The age or life stage provides context, not a complete diagnosis.

What is the difference between vaginal and vulvar dryness?

Vaginal dryness occurs within the vaginal canal.

Vulvar dryness affects external or partially external structures, including the labia and vestibule surrounding the vaginal opening.

A woman may experience one or both. Products should be selected and applied according to the anatomical location for which they were designed.

What is established—and what remains uncertain?

Established

Lubricants and vaginal moisturizers serve different purposes.[1]
Lubricants can reduce friction during sexual activity.
Vaginal moisturizers may relieve dryness in some women.[1,2]
Clinical results differ among products and studies.[2–5]
Persistent dryness, burning, or pain can have multiple causes.
A product that repeatedly causes discomfort should be reassessed rather than automatically escalated.

Supported but still limited

Hyaluronic-acid and polycarbophil formulations may improve dryness and other GSM symptoms in some women.[4,5]
Product pH, osmolality, and ingredients may influence epithelial and microbial effects.[6–8]
Different anatomical sites may require different formulations or approaches.

Not established

That all moisturizers act only as inert surface coatings.
That every moisturizer alters tissue biology.
That a plateau proves progressive tissue damage.
That burning always reflects a damaged barrier.
That more frequent use will necessarily improve results.
That an incomplete response proves a need for estrogen, testosterone, or DHEA.
That evidence for one moisturizer applies to every product in the category.
That laboratory epithelial effects predict clinical injury in every user.

The central idea

Vaginal moisturizers and lubricants can be useful without being complete solutions.

A lubricant reduces friction. A moisturizer supports longer-lasting hydration. Some formulations may also influence local tissue measures, while others may provide primarily symptomatic relief.

When relief becomes incomplete, the correct conclusion is not automatically that the product failed or that the tissue requires a stronger intervention.

The more useful question is:

Has the symptom changed, has the formulation become irritating, or is the product being asked to address a biological problem outside its intended function?

That distinction helps women move from repeated trial and error toward more precise care.

By Laura Kelly, DAOM, L.Ac., Dipl. O.M. A California-licensed primary care provider and nationally board-certified clinician with a clinical focus on women’s health and healthy aging. Research Scholar, Ronin Institute. ORCID: 0000-0001-6586-7308. More about Dr. Kelly

Last scientifically reviewed: July 2026

Educational note: This article provides general scientific education and is not a diagnosis or individualized treatment recommendation. Persistent, new, or worsening vulvar, vaginal, sexual, or urinary symptoms should be evaluated by an appropriately qualified healthcare professional.

References

The NAMS 2020 Genitourinary Syndrome of Menopause Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992. https://doi.org/10.1097/GME.0000000000001609
Danan ER, Sowerby C, Ullman KE, et al. Hormonal treatments and vaginal moisturizers for genitourinary syndrome of menopause: a systematic review. Annals of Internal Medicine. 2024;177(10):1400–1414. https://doi.org/10.7326/ANNALS-24-00610
Mitchell CM, Reed SD, Diem S, et al. Efficacy of vaginal estradiol or vaginal moisturizer versus placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial. JAMA Internal Medicine. 2018;178(5):681–690. https://doi.org/10.1001/jamainternmed.2018.0116
Cagnacci A, Barattini DF, Casolati E, Pecoroni A, Mangrella M, Patrascu LC. Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: a prospective randomized trial. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2022;270:239–245. https://doi.org/10.1016/j.ejogrb.2022.01.021
Agrawal S, LaPier Z, Nagpal S, et al. A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause. Menopause. 2024;31(9):750–755. https://doi.org/10.1097/GME.0000000000002390
Ayehunie S, Wang YY, Landry T, Bogojevic S, Cone RA. Hyperosmolal vaginal lubricants markedly reduce epithelial barrier properties in a three-dimensional vaginal epithelium model. Toxicology Reports. 2018;5:134–140. https://doi.org/10.1016/j.toxrep.2017.12.011
Wilkinson EM, Łaniewski P, Herbst-Kralovetz MM, Brotman RM. Personal and clinical vaginal lubricants: impact on local vaginal microenvironment and implications for epithelial cell host response and barrier function. The Journal of Infectious Diseases. 2019;220(12):2009–2018. https://doi.org/10.1093/infdis/jiz412
Łaniewski P, Owen KA, Khnanisho M, Brotman RM, Herbst-Kralovetz MM. Clinical and personal lubricants impact the growth of vaginal Lactobacillus species and colonization of vaginal epithelial cells: an in vitro study. Sexually Transmitted Diseases. 2021;48(1):63–70. https://doi.org/10.1097/OLQ.0000000000001272

Cart 0

Sorry, looks like we don't have enough of this product.

Why do Vaginal Moisturizers and Lubricants Stop Short of Full Relief?